Literature DB >> 25411361

Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation.

Jinghong Chen1, John H Winston1, Yu Fu1, Jutatip Guptarak1, Kathryn L Jensen1, Xuan-Zheng Shi1, Thomas A Green2, Sushil K Sarna3.   

Abstract

Psychological disorders are prevalent in patients with inflammatory bowel disease; the underlying mechanisms remain unknown. We tested the hypothesis that ulcerative colitis-like inflammation induced by dextran sodium sulfate (DSS) exacerbates the ongoing spontaneous activity in colon-projecting afferent neurons that induces abdominal discomfort and anxiety, and depressive-like behaviors in rats. In this study, we used the conditioned place preference and standard tests for anxiety- and depression-like behaviors. DSS rats developed anxiety- and depression-like behaviors 10 to 20 days after the start of inflammation. Single-fiber recordings showed an increase in the frequency of spontaneous activity in L6-S1 dorsal root ganglion (DRG) roots. Prolonged desensitization of transient receptor potential vanilloid 1 (TRPV1)-expressing colonic afferents by resiniferatoxin (RTX) suppressed the spontaneous activity, as well as the anxiety- and depressive-like behaviors. Reduction in spontaneous activity in colon afferents by intracolonic administration of lidocaine produced robust conditioned place preference (CPP) in DSS rats, but not in control rats. Patch-clamp studies demonstrated a significant decrease in the resting membrane potential, lower rheobase, and sensitization of colon-projecting L6-S1 DRG neurons to generate trains of action potentials in response to current injection in DSS rats. DSS inflammation upregulated the mRNA levels of transient receptor potential ankyrin 1 and TRPV1 channels and downregulated that of Kv1.1 and Kv1.4 channels. Ulcerative colitis-like inflammation in rats induces anxiety- and depression-like behaviors, as well as ongoing abdominal discomfort by exacerbating the spontaneous activity in the colon-projecting afferent neurons. Alterations in the expression of voltage- and ligand-gated channels are associated with the induction of mood disorders following colon inflammation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  anxiety; depression; inflammatory bowel disease; spontaneous activity in visceral afferent neurons; visceral hypersensitivity

Mesh:

Substances:

Year:  2014        PMID: 25411361      PMCID: PMC4281679          DOI: 10.1152/ajpregu.00298.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  37 in total

1.  Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats.

Authors:  V Chapman; R Suzuki; H L Chamarette; L J Rygh; A H Dickenson
Journal:  Pain       Date:  1998-04       Impact factor: 6.961

Review 2.  Pitfalls in cytokine analysis in inflammatory bowel disease.

Authors:  C Fiocchi; K Fukushima; S A Strong; K Ina
Journal:  Aliment Pharmacol Ther       Date:  1996       Impact factor: 8.171

3.  Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome.

Authors:  G Nicholas Verne; Arup Sen; Donald D Price
Journal:  J Pain       Date:  2005-08       Impact factor: 5.820

4.  Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons.

Authors:  K C Kajander; G J Bennett
Journal:  J Neurophysiol       Date:  1992-09       Impact factor: 2.714

5.  Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

Authors:  G Addolorato; E Capristo; G F Stefanini; G Gasbarrini
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

6.  IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior.

Authors:  Itta M Minderhoud; Bas Oldenburg; Josta A Wismeijer; Gerard P van Berge Henegouwen; André J P M Smout
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

7.  Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?

Authors:  Joel Sach; Roger Bolus; Leah Fitzgerald; Bruce D Naliboff; Lin Chang; Emeran A Mayer
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

8.  Psychiatric illness in patients with inflammatory bowel disease.

Authors:  H Andrews; P Barczak; R N Allan
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

9.  Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Authors:  Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser
Journal:  Psychosom Med       Date:  2004 Jan-Feb       Impact factor: 4.312

10.  A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury.

Authors:  Philip J Siddall; Joan M McClelland; Susan B Rutkowski; Michael J Cousins
Journal:  Pain       Date:  2003-06       Impact factor: 6.961

View more
  24 in total

1.  Role of brain-derived neurotrophic factor in the pathogenesis of distention-associated abdominal pain in bowel obstruction.

Authors:  Y Fu; Y M Lin; J H Winston; R Radhakrishnan; L-Y M Huang; X Z Shi
Journal:  Neurogastroenterol Motil       Date:  2018-05-21       Impact factor: 3.598

2.  Resilience or susceptibility to traumatic stress: Potential influence of the microbiome.

Authors:  Arax Tanelian; Bistra Nankova; Mariam Miari; Roxanna J Nahvi; Esther L Sabban
Journal:  Neurobiol Stress       Date:  2022-05-27

Review 3.  TRP channel functions in the gastrointestinal tract.

Authors:  Xiaoyun Yu; Mingran Yu; Yingzhe Liu; Shaoyong Yu
Journal:  Semin Immunopathol       Date:  2015-10-12       Impact factor: 9.623

Review 4.  Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.

Authors:  Rachel D Moloney; Anthony C Johnson; Siobhain M O'Mahony; Timothy G Dinan; Beverley Greenwood-Van Meerveld; John F Cryan
Journal:  CNS Neurosci Ther       Date:  2015-12-10       Impact factor: 5.243

Review 5.  The role of oxidative stress in anxiety disorder: cause or consequence?

Authors:  Alessandra das Graças Fedoce; Frederico Ferreira; Robert G Bota; Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Res       Date:  2018-06-04

6.  Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase.

Authors:  Haley A Vecchiarelli; Maria Morena; Catherine M Keenan; Vincent Chiang; Kaitlyn Tan; Min Qiao; Kira Leitl; Alessia Santori; Quentin J Pittman; Keith A Sharkey; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

7.  Pathogenesis of abdominal pain in bowel obstruction: role of mechanical stress-induced upregulation of nerve growth factor in gut smooth muscle cells.

Authors:  You-Min Lin; Yu Fu; John Winston; Ravi Radhakrishnan; Sushil K Sarna; Li-Yen M Huang; Xuan-Zheng Shi
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

8.  Precision Lactobacillus reuteri therapy attenuates luminal distension-associated visceral hypersensitivity by inducing peripheral opioid receptors in the colon.

Authors:  Shrilakshmi Hegde; You-Min Lin; Yu Fu; Tor Savidge; Xuan-Zheng Shi
Journal:  Pain       Date:  2020-12       Impact factor: 7.926

9.  Chronic stress accelerates the process of gastric precancerous lesions in rats.

Authors:  Jiayi Zheng; Weiwu Cai; Xuen Lu; Wei He; Ding Li; Haoyu Zhong; Liangjun Yang; Siyi Li; Haishan Li; Sereen Rafee; Ziming Zhao; Qi Wang; Huafeng Pan
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

10.  Isolated nociceptors reveal multiple specializations for generating irregular ongoing activity associated with ongoing pain.

Authors:  Max A Odem; Alexis G Bavencoffe; Ryan M Cassidy; Elia R Lopez; Jinbin Tian; Carmen W Dessauer; Edgar T Walters
Journal:  Pain       Date:  2018-11       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.